Stay informed with the latest updates for the inheritable blood disorders community.

Medical
EMA Reviews Recurrence of HBV, Liver Cancer in Patients Taking Antivirals
EMA Reviews Recurrence of HBV, Liver Cancer in Patients Taking Antivirals
Medical
New Medscape Activity Looks at Integrating Extended Half Life Products into Clinical Practice
Digital Hemophilia Treatment Center Monitoring…
Medical
NHF to Collaborate on Clinical Practice Guidelines for von Willebrand Disease
Three New MASAC Documents Available
Medical
Women Leaders in Hematology Featured in New Article
Women Leaders in Hematology Featured in New Article
NBDF & Community
65 Million and Counting
65 Million and Counting
Medical
Study of 50 Years of Hemophilia Healthcare Outcomes Yields Surprises
Study of 50 Years of Hemophilia Healthcare Outcomes Yields Surprises
Medical
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Bayer’s KOVALTRY
NBDF & Community
NHF CEO's Bleeding Disorders Awareness Month blog post featured on Huffington Post
NHF CEO's Bleeding Disorders Awareness Month blog post…
Medical
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves New Recombinant Factor IX Therapy for Hemophilia B
NBDF & Community
MASAC Update on SIPPET
MASAC Update on SIPPET
Industry
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Generic Version of Tranexamic Acid
NBDF & Community
NHF and Believe Limited Join Forces
NHF and Believe Limited Join Forces
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Teaching Children about Bleeding Disorders in NHF’s Nurses’ Guide
NBDF & Community
Take the Red Tie Challenge for Bleeding Disorders Awareness Month!
Take the Red Tie Challenge for Bleeding Disorders Awareness Month!
Industry
Pfizer and King’s College of London to Develop Gene Therapy Technologies
Pfizer and King’s College of London to Develop Gene Therapy Technologies